Enhancing Calm in Arab Elderly With Dementia

Launched by MOSTAFA SHABAN · Jan 19, 2024

Keywords

ClinConnect Summary

This clinical trial is centered on a novel approach to dementia care, specifically targeting the Arab elderly demographic. It uniquely combines three elements - Snoezelen therapy, aromatherapy, and the use of personal items - to address agitation, a common and challenging symptom in dementia patients.

Snoezelen Therapy Implementation:

Custom-designed Snoezelen rooms will be used, equipped with lights, colors, sounds, and textures to stimulate senses in a controlled manner.

Sessions will be tailored to individual patient needs and preferences, monitored by trained staff.

Aromatherapy App...

Gender

ALL

Eligibility criteria

• For the study \"Enhancing Calm in Arab Elderly with Dementia: Integrating Snoezelen Methods with Aromatherapy and Personal Items to Reduce Agitation\", here are the suggested Inclusion and Exclusion Criteria:
• Inclusion Criteria:
• • Age: Participants must be 65 years to 90 years
• • Diagnosis: Clinical diagnosis of dementia required.
• • Ethnicity: Must be of Arab descent.
• • Agitation Levels: Must show agitation signs based on a standardized scale.
• • Cognitive Function: Adequate cognitive function for study participation, verified by standard assessment.
• Exclusion Criteria:
• • Severe Medical Conditions: Individuals with severe medical conditions that could affect study participation or health.
• • Advanced Dementia: Patients with very advanced dementia stages, unable to engage in study activities.
• • Allergies: Known allergies to aromatherapy products used in the study.
• • Recent Medication Changes: Significant changes in dementia medication regimen before the study.